The Emergency Committee on COVID-19 met on 29 October to review the situation and progress made on the temporary recommendations. They advised that the pandemic still constituted a public health emergency of international concern, and urged a focus on response efforts based on lessons learned and strong science.
WHO Director-General Dr Tedros Adhanom Ghebreyesus accepted the advice of the committee, stating that “WHO will continue to work in partnership across the world to drive science, solutions and solidarity.”
The committee expressed appreciation for WHO’s leadership and activities throughout the global response, including its critical role in developing evidence-based guidance, providing countries with technical assistance and critical supplies and equipment, communicating clear information and addressing misinformation, and convening the Solidarity Trials and the Access to COVID-19 Tools (ACT) Accelerator.
The committee provided concrete and targeted advice for WHO and countries to focus on in the coming months. It emphasized the importance of evidence-informed, risk-based and coherent measures in relation to international traffic, surveillance and contract tracing efforts, maintaining essential health services including mental health services, and preparing plans for future COVID-19 vaccines. The committee urged countries to avoid politicization of the pandemic response, seen as a major detriment to global efforts. Read the full statement.
As the committee convened for the fifth time, global reported cases had reached 44 million, with over 1.1 million people having lost their lives to COVID-19.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022